术前血清碱性磷酸酶预测动静脉内瘘成熟失败
本研究通过多组学分析发现ALPL基因为动静脉内瘘(AVF)成熟失败的核心枢纽基因,并在55例前瞻性临床队列中验证。术前血清碱性磷酸酶(ALP)每升高10 U/l,AVF成熟成功的调整比值比为0.75(95%CI 0.55-0.98,P=0.048)。重组人TNSALP蛋白可剂量依赖性抑制体外血管形成。
要点
- 术前血清ALP升高与AVF成熟成功几率降低独立相关。
- ALPL在失败AVF组织中上调,主要定位于PLA2G2A+成纤维细胞。
- 血清ALP或可作为术前AVF成熟风险评估的实用生物标志物。
核心结论
- ALPL是AVF成熟失败的候选介导基因,血清ALP可能作为术前风险分层的实用生物标志物。
研究设计与样本
- 采用整合多组学方法(转录组数据集GSE220796和GSE119296的WGCNA与机器学习分析,单细胞RNA测序GSE250469定位)识别枢纽基因。
- 在前瞻性临床队列(n=55)中验证,并行人脐静脉内皮细胞管形成功能实验。
主要发现
- ALPL基因在失败AVF中上调,主要表达于PLA2G2A+成纤维细胞。
- 临床队列中失败AVF组织TNSALP蛋白水平较高,且与术前血清ALP水平相关(r=0.38,P=0.018)。
- 术前血清ALP每升高10 U/l,AVF成熟成功的调整OR为0.75(95%CI 0.55-0.98,P=0.048)。
- 重组人TNSALP蛋白剂量依赖性抑制人脐静脉内皮细胞管形成(P<0.05)。
临床怎么用
- 术前可考虑检测血清ALP,辅助识别AVF成熟失败高风险患者。
- 对血清ALP较高的患者,应加强术后内瘘成熟监测与评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Arteriovenous fistula (AVF) maturation failure remains a major obstacle for hemodialysis, yet its underlying molecular drivers are poorly characterized. The identification of key regulatory genes and clinically applicable biomarkers is critical for improving preoperative risk assessment. METHODS: We employed an integrative multiomics approach to unbiasedly identify hub genes. Transcriptomic datasets (GSE220796 and GSE119296) were analyzed using weighted gene coexpression network analysis (WGCNA) and machine learning. Cellular localization was defined via single-cell RNA-sequencing (GSE250469). Findings were validated in a prospective clinical cohort (n = 55) and through functional tube formation assays with human umbilical vein endothelial cells. RESULTS: The tissue-nonspecific alkaline phosphatase (ALPL) gene, which encodes tissue-nonspecific alkaline phosphatase (TNSALP), was identified as a core hub gene upregulated in failed AVFs, predominantly in PLA2G2A + fibroblasts. In the clinical cohort, tissue TNSALP protein levels were higher in failed AVFs and correlated with preoperative serum alkaline phosphatase (ALP) levels (r = 0.38, P = 0.018). Higher preoperative serum ALP was independently associated with lower odds of successful AVF maturation (adjusted odds ratio [OR]: 0.75 per 10 units per liter (U/l) increase, 95% confidence interval (CI): 0.55-0.98, P = 0.048). Functionally, recombinant human TNSALP protein dose-dependently suppressed human umbilical vein endothelial cells tube formation in vitro (P < 0.05). CONCLUSION: Our study identifies ALPL as a candidate mediator associated with AVF maturation failure and suggests that serum ALP, a routine clinical test, may serve as a practical biomarker for preoperative risk stratification.
引用
- Si T, Yu H, Shen Z, et al. Preoperative Serum Alkaline Phosphatase Predicts Arteriovenous Fistula Maturation Failure. Kidney Int Rep. 2026. PMID: 42569269. doi:10.1016/j.ekir.2026.106687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。